The term critical limb ischemia refers to an ailment characterized by chronic ischemic rest pain, ulcers, or gangrene in one or both legs attributable to quantitatively proven arterial occlusive disease, this was the same problem Nawab was suffering from. Peripheral arterial disease affects 12% of the adult populace and up to 20% of elderly individuals. The most severe form of peripheral arterial disease is critical limb ischemia which transpires when arterial blood flow is restricted so sternly that perfusion of capillary beds is insufficient to sustain tissue sustainability.

Diabetic ischemic foot had led Nawab to experience chronic pain, sepsis, tissue loss and doctors were afraid they might have to execute eventual amputation, which can be fatal. Conventional treatment encompasses bypass surgery and balloon angioplasty. However, when he came to India at Stem Cell care India for the treatment, he learnt that bone marrow mesenchymal stem cells therapy augmented lower limb perfusion and promoted foot ulcer healing in diabetic patients with critical limb ischemia. Revascularization is the refurbishment of blood flow to a body portion or organ that has suffered ischemia, normally accomplished by surgical means. Non-revascularizable critical limb ischemia is the most severe phase of peripheral arterial disease, with no therapeutic option. This mesenchymal cells treatment sturdily improves revascularization wound healing and tissue perfusion in ischemic limbs. Stem Cell Care India has state-of-the-art technologies and human resource to help you get captivating treatment possibilities for Critical Limb Ischemia via the use of stem cells. This clinic ranks as one of the best healthcare systems as it we offers high quality stem cells treatments for just a fraction of the price you get in other countries.